PTIX

PTIX

USD

Protagenic Therapeutics Inc. Common Stock

$2.150-0.070 (-3.153%)

Echtzeitkurs

Healthcare
Biotechnologie
Vereinigte Staaten

Kursdiagramm

Loading Chart...

Schlüsselkennzahlen

Marktkennzahlen
Unternehmensfundamentaldaten
Handelsstatistiken

Marktkennzahlen

Eröffnung

$2.220

Hoch

$2.290

Tief

$2.140

Volumen

0.03M

Unternehmensfundamentaldaten

Marktkapitalisierung

4.1M

Branche

Biotechnologie

Land

United States

Handelsstatistiken

Durchschnittliches Volumen

2.71M

Börse

NCM

Währung

USD

52-Wochen-Spanne

Tief $2.09Aktuell $2.150Hoch $15.26

Ähnliche Nachrichten

AccessWire

Protagenic Therapeutics Provides Update on Form 10-Q Filing Timeline and Nasdaq Compliance

Delay Attributable to Merger-Related Financial Consolidation NEW YORK, NY / ACCESS Newswire / August 22, 2025 / Protagenic Therapeutics, Inc. , a biopharmaceutical company developing novel neuro-active

Mehr anzeigen
Protagenic Therapeutics Provides Update on Form 10-Q Filing Timeline and Nasdaq Compliance
AccessWire

Protagenic Therapeutics Advances PT00114 into Multiple-Dose Phase 1 Trial; Positioning for Phase 2 in Stress & Mood Disorders

Dosing Completion Expected by End of August; Phase 2 Trial Expected to Begin in 1Q 2026 NEW YORK, NY / ACCESS Newswire / August 21, 2025 / Protagenic Therapeutics, Inc. , a biopharmaceutical company

Mehr anzeigen
Protagenic Therapeutics Advances PT00114 into Multiple-Dose Phase 1 Trial; Positioning for Phase 2 in Stress & Mood Disorders